CELLCOM ISRAEL LTD's ticker is CELJF and the CUSIP is M2196U109. A total of 54 filers reported holding CELLCOM ISRAEL LTD in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,000,000 | -22.7% | 343,600 | -16.3% | 0.00% | – |
| Q4 2019 | $1,293,000 | +3053.7% | 410,558 | +2693.3% | 0.00% | – |
| Q3 2019 | $41,000 | -50.6% | 14,698 | -36.4% | 0.00% | – |
| Q1 2019 | $83,000 | -44.3% | 23,118 | -8.9% | 0.00% | – |
| Q4 2018 | $149,000 | +9.6% | 25,390 | +27.0% | 0.00% | – |
| Q3 2018 | $136,000 | -18.1% | 19,995 | +22.7% | 0.00% | – |
| Q4 2017 | $166,000 | -85.0% | 16,291 | -85.8% | 0.00% | – |
| Q2 2017 | $1,107,000 | -22.2% | 114,800 | -17.1% | 0.00% | -100.0% |
| Q1 2017 | $1,423,000 | +1397.9% | 138,400 | +455.8% | 0.00% | – |
| Q2 2015 | $95,000 | -46.6% | 24,900 | +69.4% | 0.00% | – |
| Q2 2014 | $178,000 | -34.1% | 14,700 | -25.0% | 0.00% | – |
| Q1 2014 | $270,000 | +74.2% | 19,600 | +76.6% | 0.00% | – |
| Q4 2013 | $155,000 | -71.0% | 11,100 | -77.1% | 0.00% | – |
| Q3 2013 | $535,000 | -4.3% | 48,400 | -20.1% | 0.00% | – |
| Q2 2013 | $559,000 | – | 60,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MEITAV INVESTMENT HOUSE LTD | 527,745 | $2,600,000 | 0.10% |
| Renaissance Technologies | 3,856,942 | $18,706,000 | 0.02% |
| Clal Insurance Enterprises Holdings Ltd | 197,526 | $895,000 | 0.01% |
| ARK Investment Management | 427,345 | $2,106,000 | 0.01% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 630,061 | $3,106,000 | 0.00% |
| Phoenix Holdings Ltd. | 20,840 | $101,000 | 0.00% |
| Qube Research & Technologies Ltd | 29,210 | $142,000 | 0.00% |
| CKW FINANCIAL GROUP | 1,000 | $5,000 | 0.00% |
| NORGES BANK | 889,375 | $4,385,000 | 0.00% |
| Swiss National Bank | 195,531 | $963,000 | 0.00% |